U.S., April 1 -- ClinicalTrials.gov registry received information related to the study (NCT07504016) titled 'Development of a Novel Cookie Formulation and Evaluation of Its Effects on Glycemic Control in Healthy Individuals' on March 25.

Brief Summary: This study will employ a randomized, open-label, crossover design to evaluate the glycemic response to newly developed cookie formulations. A total of 20 healthy adults aged 20-70 years with a body mass index (BMI) between 18.5 and 25 kg/m² will be recruited. Participants will first complete a standard reference test using 50 g of glucose solution, followed by random assignment to consume four to five different cookie formulations in separate test sessions with a washout period of at le...